Breakthrough Cancer Research

Our key decision makers

A number of bodies work together to ensure that Breakthrough Cancer Research makes the best use of the funds we receive and continues to carry out world-class research.

In this section you can read about the key decision makers for the charity and their roles and responsibilities:

• our Executive Management Team, which is responsible for the day to day operations of the organisation including the implementation of the strategic direction of the research
• our Board of Directors, which performs and advisory and governance role for the charity
• our Scientific Advisory Board, which advises on the organisation's scientific strategy and policy
• our Development Committee, which advises and supports fundraising strategy

Executive Management Team

The Executive Management Team brings together the leaders for the operational functions of Breakthrough Cancer Research and include:

• Professor Gerry O’Sullivan – Director in Chief
• Dr. Declan Soden – General Manager
• Orla Dolan – Fundraising Manager
• Dr. Sharon McKenna - Principal Investigator
• Dr. Mark Tangney – Principal Investigator

Board of Directors

The Boards of Directors of the Breakthrough Cancer Research encompass a group of highly dedicated individuals with diverse backgrounds who bring expertise and passion to our vision and mission.

• Dr. Declan Farrell - Chairman
• Prof. Gerald C. O'Sullivan - Founder/Director
• Dr. Ita Lynch
• Mr. Bryan Mohally
• Prof. Eamonn Quigley
• Prof. Brendan Buckley
• Leslie Buckley
• Michael Horgan

Scientific Advisory Board

The Scientific Advisory Board (SAB) meets once a year to provide advice to the Executive Management Team and Board of Directors on key scientific strategy and policy issues.

The SAB has the following members:

• Dr. Owen O’Connor
  (Deputy Director of Clinical Research and Cancer Treatment & Chief of the Division of Medical Oncology and Hematologic Malignancies, NYU Langone Medical Center, New York, USA)
• Dr. Kevin Harrington
  (Senior Lecturer at The Institute of Cancer Research and Honorary Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, UK)
• Dr. Michael Goggins
  (Professor of Pathology, Medicine and Oncology at the Johns Hopkins Medical Institutions, USA)
• Elaine Harrington
  (Chief Executive Officer of Socrates Healthcare, Former SVP of Life Sciences at Enterprise Ireland)

Development Committee

• Robin O’Sullivan
• Sean Ryan
• Niall Welch
• Niamh Sullivan
• John Dwyer
• Orla Dolan
• Helena Slattery